Zendehdel Baher, S.; Yaqoubi, S.; Asare-Addo, K.; Hamishehkar, H.; Nokhodchi, A.
Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension. Pharmaceutics 2022, 14, 895.
https://doi.org/10.3390/pharmaceutics14050895
AMA Style
Zendehdel Baher S, Yaqoubi S, Asare-Addo K, Hamishehkar H, Nokhodchi A.
Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension. Pharmaceutics. 2022; 14(5):895.
https://doi.org/10.3390/pharmaceutics14050895
Chicago/Turabian Style
Zendehdel Baher, Shalaleh, Shadi Yaqoubi, Kofi Asare-Addo, Hamed Hamishehkar, and Ali Nokhodchi.
2022. "Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension" Pharmaceutics 14, no. 5: 895.
https://doi.org/10.3390/pharmaceutics14050895
APA Style
Zendehdel Baher, S., Yaqoubi, S., Asare-Addo, K., Hamishehkar, H., & Nokhodchi, A.
(2022). Dry Powder Formulation of Simvastatin Nanoparticles for Potential Application in Pulmonary Arterial Hypertension. Pharmaceutics, 14(5), 895.
https://doi.org/10.3390/pharmaceutics14050895